Home 2023

Merck & Co

Conscious Re-Coupling: M&A Comes Back Surely, If Slowly
Bioprocessing

Conscious Re-Coupling: M&A Comes Back Surely, If Slowly

Alex Philippidis -
0
Alliance for Genomic Discovery Announces Five Founding Biopharma Members
Industry News

Alliance for Genomic Discovery Announces Five Founding Biopharma Members

Julianna LeMieux, PhD -
0
Biopharma Collaboration: Roadmap Towards the Facility of the Future
Bioprocessing

Biopharma Collaboration: Roadmap Towards the Facility of the Future

Kathy Vuksanaj -
0
Variant Bio Turns Focus from Identifying Genomic Variants to Drug Discovery
Drug Discovery

Variant Bio Turns Focus from Identifying Genomic Variants to Drug Discovery

John Sterling -
0
Multiple Vaccine Technologies Converge on Respiratory Syncytial Virus
Insights

Multiple Vaccine Technologies Converge on Respiratory Syncytial Virus

Kathy Vuksanaj -
0
AACR: Moderna, Merck Present Positive Data for Personalized Cancer Vaccine
Cancer

AACR: Moderna, Merck Present Positive Data for Personalized Cancer Vaccine

Alex Philippidis -
0
Merck to Acquire Prometheus Biosciences for $10.8B
Drug Discovery

Merck to Acquire Prometheus Biosciences for $10.8B

Alex Philippidis -
0
Merck Biomanufacturing Optimization Sees Major Production Gains
News

Merck Biomanufacturing Optimization Sees Major Production Gains

John Sterling -
0
StockWatch: Antitrust Fears Dampen Support for $43B Pfizer-Seagen Deal
News

StockWatch: Antitrust Fears Dampen Support for $43B Pfizer-Seagen Deal

Alex Philippidis -
0
StockWatch: Moderna Looks to Accelerate Cancer Vaccine
News

StockWatch: Moderna Looks to Accelerate Cancer Vaccine

Alex Philippidis -
0
123...40Page 1 of 40
Copyright © 2023 Genetic Engineering & Biotechnology News. All Rights Reserved.